AHA

October 24, 2013

Shining a light on night blindness

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.

By VUMC News and Communications
July 29, 2013

Motor protein revs up cell division

A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.

By Leigh MacMillan
July 26, 2013

Reducing fatal rhythms after heart attack

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.

By Courtney M. Campbell
March 28, 2013

Acetaminophen: protective in sepsis?

In critically ill patients with sepsis, plasma hemoglobin may be a new indicator of disease severity – and a potential target for treatment with acetaminophen.

By Leigh MacMillan
February 14, 2013

Cell connections key in valve disease

A protein that connects cells together participates in the calcification that occurs in heart valve disease.

By Leigh MacMillan
February 1, 2013

Cell source of heart’s blood vessels

An unexpected group of cells generates the coronary arteries and may be useful for regeneration therapies following injury to the heart.

By Leigh MacMillan
December 26, 2012

Preventing hardened heart valves

Blocking a serotonin receptor may provide a novel therapy for heart valve disease.
By Leigh MacMillan
November 15, 2012

Heart Association honors Roden’s research efforts

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.
By Kathy Whitney
March 4, 2011

Chasing Foxd3’s role in stem cells

Researchers use genetic manipulations in mice and single-cell analyses to help explain stem cell regulation.
By Leigh MacMillan